Fibrinolysis

1,547 views

Published on

0 Comments
8 Likes
Statistics
Notes
  • Be the first to comment

No Downloads
Views
Total views
1,547
On SlideShare
0
From Embeds
0
Number of Embeds
4
Actions
Shares
0
Downloads
74
Comments
0
Likes
8
Embeds 0
No embeds

No notes for slide

Fibrinolysis

  1. 1. Prepared By : Muhammad Halmii (016-3626470) TEAM GENESIS
  2. 2.  DEFINE  CAUSE (-)  DISEASE PROCESS (PATHOGENESIS) (X)  TYPES (X)  EFFECT (- )  CLINICAL MENIFESTATIONS (SIGNS & SYMPTOMS) TEAM GENESIS
  3. 3. Blood Clot: A thickened mass in the blood formed by tiny substances called platelets. Clots form to stop bleeding preventing excessive blood loss Fibronolysis: (Lysis Of Fibrin) Fibrinolysis is a process that prevents blood clots from growing and becoming pathologic BOTH PROCESS ARE STEPS OF WOUND HEALING & PHYSIOLOGICAL TEAM GENESIS
  4. 4. Anticoagulant Coagulant Eg: Heparin, Antithrombin Eg: Fibrin Thrombin Excessive:Hemophilia Excessive:Thrombosis TEAM GENESIS
  5. 5. Haemostasis Inflammation GranulationRemodelling / Maturation Proliferative Angiogenesis Overlaps Blood Clot Fibrinolysis TEAM GENESIS
  6. 6. TEAM GENESIS
  7. 7. Local Response : Release Thromboxane Systemic Response : Adrenal Medulla Regulates Hormones (i.e epinephrine & norepinephrine) Stimulates Cross Bridge Of Smooth Muscle Cell {i.e. contraction} Exposes Large area of collagen surface to BV & Limits Blood Loss Initiates Platelet Activation TEAM GENESIS
  8. 8. Primary Secondary TEAM GENESIS
  9. 9.  Made In Bone Marrow From The Megakaryocytes’ Cytoplasm  Not A Cell  Below Normal Count = Thrombocytopenia  High Normal Count = Thrombisis  F(x) = Hemostatic Plug etc.  Binding Site = Between Platelets , VWFTEAM GENESIS
  10. 10.  Immediate Initiation (20 sec) & Immediate Completion (Few Minutes)  Platelets Undergo Conformational Shape Change To Enhance Clot  Main Components : Platelets 100%  Moderately Stable TEAM GENESIS
  11. 11.  Platelet adhesion: First event in hemostasis is the adhesion of platelets to exposed subendothelium. mediated by von Willebrand factor (vWf), which binds to glycoprotein Ib.  Platelet activation:The adhesion of platelets to the vessel wall activates them, causing the platelets to change shape & activates the receptor glycoprotein IIb/IIIa. Upon activation, platelets synthesize and release thromboxane A2 (TXA2) and platelet activating factor (PAF), which are potent platelet aggregating agonists and vasoconstrictors. {POSITIVE FEEDBACK}  PRIMARY HEMOSTASIS TEAM GENESIS
  12. 12.  Synthesized At Gene No. 12  F(x) = Grips Platelets At Glycoprotein Ib To Stabilize Clot TEAM GENESIS
  13. 13.  Converts Fibrinogen To Fibrin  Activates Factor 13 (Hardening Of )  Generates Procoagulant Activity  Activates (Protein C) Fibrinolysis After A While TEAM GENESIS
  14. 14.  Involves Both Intrinsic (Inside BV) & Extrinsic (Outside BV) Activity To Generate Thrombin Which Ultimately Generates Fibrin  Happens After Primary Hemostasis  Extrinsic Initiate But Produces Little Fibrin While Intrinsic Amplifies Action  INtrinsic  Twelve  Eleven  Nina  Eight  Ten 12 11 9 8 10 5 7 TEAM GENESIS
  15. 15.  Initiation of coagulation: The coagulation cascade is initiated by the extrinsic pathway with the generation/exposure of tissue factor. Tissue factor then binds to factor VII and this complex activates factor X. Factor X, in the presence of factor V, calcium and platelet phospholipid ("prothrombinase complex") then activate prothrombin to thrombin. This pathway is rapidly inhibited by a lipoprotein-associated molecule, called tissue factor pathway inhibitor. However, the small amount of thrombin generated by this pathway (before inhibition) activates factor XI of the intrinsic pathway, which amplifies the coagulation cascade.  Amplification of coagulation: The coagulation cascade is amplified by the small amounts of thrombin generated by the extrinsic pathway. This thrombin activates the intrinsic pathway by activation of factors TENET. generating large amounts of thrombin. Thrombin, in turn, then cleaves fibrinogen to form soluble fibrin monomers, which then spontaneously polymerize to form the soluble fibrin polymer. Thrombin also activates factor XIII, which, together with calcium, serves to crosslink and stabilize the soluble fibrin polymer, forming cross linked (insoluble) fibrin. TEAM GENESIS
  16. 16. TEAM GENESIS
  17. 17.  Clot Would Be Dangerous If It Were To Expand Beyond Boundary Thus They Are Inhibited By: Clotting Factors Are Rapidly Inhibited At Other Places (Enzymes In Blood Inactivate Clotting Factors) End Product Inhibition Of Fibrin (The Higher Fibrin, The Higher The Intensity Of Thrombin Inhibition) TEAM GENESIS
  18. 18.  Activated Protein C & Protein S  Tissue Factor Inhibitor  Anti-Thrombin  Heparin Cofactor II GO AND READ YRSELF  In Short, They Prevent Unnecessary Clotting At Unwounded Areas PREVENTS CLOT FORMATION BUT DOES NOT DESTROYS THE CLOT !!!!! TAKE NOTE TEAM GENESIS
  19. 19.  The Clot Stimulates Tissue Plasmin Activator  TPA Converts Plasminogen To Plasmin  Plasminogen Is Found In Blood  Clot Removal Happens At A Slow Pace To Enable Endothelial To Divide For Healing TEAM GENESIS
  20. 20.  Destroys Fibrinogen & Fibrin  Produces D-Dimer TEAM GENESIS
  21. 21.  Reaction Time Is Delayed  Prolonged Clotting Time  Increase Blood Loss TEAM GENESIS
  22. 22.  Vascular Disorder  Scurvy (Scurvy is a disease resulting from a deficiency of vitamin C, which is required for the synthesis of collagen in humans.)  Bruising Vulneribility (Lack Of Endothelial Integrity)  Platelets Disorder  Thrombocytopenia (Platelet count below 50,000 per microlitre.)  Platelets Dysfunction (Platelets Lacking Of Receptors)  Coagulation Disorder  Hemophilia (Lacking Of Intrinsic Factors) TEAM GENESIS
  23. 23.  Blood Count  Bleeding Time (Diagnose Thrombocytopenia)  Prothrombin Time (Measure Extrinsic Factor) PT Excellent  Activated Partial Thromboplastin Time (Intrinsic & Common)  Thrombin Time (Tome For Fibrinogen To Fibrin Formation)  Mixing Test (Detect Factor Dificiency) TEAM GENESIS

×